BLTE CIK: 1889109

Belite Bio, Inc. ADR

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.47
FY22:
−11.5
FY23:
−29.8
FY24:
−29.2
FY25:
−37.0
Change from FY21 to FY25
millions USD
FY21:
−0.06
FY22:
−0.39
FY23:
−0.06
FY24:
−111
FY25:
−305
Change from FY21 to FY25
millions USD
FY21:
−0.58
FY22:
37.0
FY23:
76.0
FY24:
83.6
FY25:
663
millions USD
FY21:
−8.27
FY22:
24.7
FY23:
46.1
FY24:
−56.5
FY25:
321
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.55
FY22:
−11.9
FY23:
−29.9
FY24:
−29.4
FY25:
−37.1

All amounts in millions USD Data source:SEC EDGAR